Tag: THC
THC Global signs cannabis medicine production deal with local cultivator Cannatrek
THC Global Group (ASX: THC) has signed a 12-month supply and production deal with Australian “seed-to-patient” medical cannabis business Cannatrek to develop and manufacture Cannatrek-branded medicine...
THC Global releases first locally-made medicinal cannabidiol for Australian patients
The first Australian-produced full-spectrum medicinal cannabidiol manufactured by diversified cannabis company THC Global (ASX: THC) has become available for prescription to Australian patients under ...
THC Global to acquire Tetra Health network of medicinal cannabis clinics
THC Global Group (ASX: THC) will pay $3 million in shares and cash to acquire the Tetra Health network of clinics which provide access to legal medicinal cannabis.
Tetra’s network comprises over 63...
THC Global sets date for first Australian medicinal cannabis prescriptions, eyes German export market
THC Global (ASX: THC) has set a firm date for when its Australian-made Canndeo branded medicinal cannabis medicines will be made available for prescription in Australia.
The company’s chief executi...
THC Global secures expanded cultivation permit, production underway for Australian patients
Medicinal cannabis developer THC Global (ASX: THC) has updated the market with news that it has received an expanded commercial cultivation permit from the Australian Office of Drug Control (ODC).
...
THC Global gets green light for commercial-scale medicinal cannabis production
THC Global Group (ASX: THC) is poised to commence commercial-scale production of medicinal cannabis after its pharmaceutical bio-floral extraction facility in Queensland was granted a manufacturing li...
THC Global produces its first batch of medicinal cannabis in Australia
After several years of planning and navigating an exhaustive path of obtaining regulatory approvals, medicinal cannabis developer THC Global (ASX: THC) has finally completed its first round of “farm-t...
THC Global to begin cannabis production at Southport facility following ODC permit
Medicinal cannabis developer THC Global (ASX: THC) has received the green light to manufacture cannabis at its Southport facility in Australia by the country’s regulator, the Office of Drug Control (O...
THC Global reports revenue in NZ and Canada, sets stage for Australian production
Medicinal cannabis developer THC Global (ASX: THC) has published an interim update of its market performance in which it reaffirmed its target of completing product validation at its Southport manufac...
THC Global receives cornerstone narcotics licences allowing medicinal cannabis production in Australia
Integrated medicinal cannabis developer THC Global (ASX: THC) has received the highly-coveted Schedule 4 and Schedule 8 narcotics licences from the Queensland Department of Health.
The approvals en...
THC Global plans early 2020 medicinal cannabis product launch to Australian patients
Integrated medicinal cannabis developer THC Global (ASX: THC) is gearing up to launch its own Australian produced medicinal cannabis products for Australian patients, with the company targeting more t...
THC Global obtains licence for Australia’s largest medicinal cannabis facility
Australian medicinal cannabis developer THC Global (ASX: THC) has been granted a second manufacturing licence, this time for its large Southport facility, making it the largest licenced bio-pharma ext...
THC Global and Eve Investments to advance medicinal cannabis partnership following manufacturing licence
In the wake of THC Global (ASX: THC) reporting it has secured its medicinal cannabis manufacturing licence, partner Eve Investments (ASX: EVE) noted the licence now paves the way for the duo to advanc...
THC’s Canndeo gets green light to manufacture medicinal cannabis extracts
THC Global's (ASX: THC) wholly-owned subsidiary Canndeo has achieved a major milestone by securing a manufacturing licence to produce cannabis extracts and tinctures in Australia.
The Australian Of...
THC Global enters Canadian market with land acquisition for new cannabis production facility
Australian-based medicinal cannabis developer THC Global (ASX: THC) is set to become a licenced cultivator following the acquisition of a 16,000 square metre site in Canada for the development of a ca...
The Hydroponics Company bulks up balance sheet with $16.7 million revaluation
Medicinal cannabis developer The Hydroponics Company (ASX: THC) has updated its shareholders with the news that it had revalued its Southport pharmaceutical manufacturing facility by $14.58 million, s...
Hydroponics Company beds into blossoming Canadian cannabis market
The influence of Australian companies grabbing a foothold in Canada’s blossoming cannabis market continues to grow as The Hydroponics Company (ASX: THC) has concluded a letter of intent (LOI) with Asc...
The Hydroponics Company lines up route to cannabis market
Medicinal cannabis developer The Hydroponics Company (ASX: THC) has provided an interim update to the market regarding its rapid progress towards becoming a fully-fledged medical cannabis producer.
...
The Hydroponics Company looks to seize tea tree extract commercial opportunity
Medicinal cannabis developer The Hydroponics Company (ASX: THC) is aiming to add significant production capabilities to its recently-acquired growing facility, and thereby continue the build-up of its...
The Hydroponics Company flying high with newly-acquired facility and substantial revenue growth
Burgeoning medical cannabis producer The Hydroponics Company (ASX: THC) is back trading on the ASX after coming out of its trading halt imposed last week.
The reason for the halt was a “material ac...
The Hydroponics Company gets import approval, provides medicinal cannabis product for Tourette’s Syndrome clinical trial
The Hydroponics Company (ASX: THC) has been given the green light to import medicinal cannabis products from its European partner Endoca after locking in a distribution deal last November.
The comp...
